Abstract
Surveillance radioiodine whole-body scans have been used for many years in the follow-up of patients with welldifferentiated thyroid cancer. However, the term “surveillance whole body scan” has been used in different ways. This short chapter (1) differentiates surveillance scans from pretreatment scans; (2) presents the objectives of surveillance scans and pretreatment scans; (3) reviews the literature for the utility of surveillance scans; and (4) presents one set of guidelines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cailleux AF, Baudin E, Travagli JP, Schlumberger RM. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000; 85:175–178.
Wartofsky L and the rhTSH-Stimulated Thyroglobulin Study Group. Management of low risk well differentiated thyroid cancer based only upon thyroglobulin measurement after recombinant human thyrotropin. Thyroid 2002; 12:583–592.
Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002; 87:1490–1498.
Wartofsky L. Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic I-131 scanning. J Clin Endocrin Metab 2002; 87:1486–1489.
Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002; 87:1499–1501.
Fatemi S, Nicoloff J, Lo Presti J, Spencer S. TSH-stimulated serum thyroglobulin in the 1–10 ng/ml range suggests a low long-term recurrence risk for papillary thyroid cancer (PTC). Washington, DC: Program of the 73rd Annual Meeting of the American Thyroid Association, 2001, 290 (Abstract 194).
Pacini F, Molinaro E, Lippi F, et al. Prediction of disease status by recombinant human TSH-stimulated serum thyroglobulin in the post surgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001; 86:5686–5690.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Van Nostrand, D. (2006). Surveillance Radioiodine Whole-Body Scans. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Humana Press. https://doi.org/10.1007/978-1-59259-995-0_32
Download citation
DOI: https://doi.org/10.1007/978-1-59259-995-0_32
Publisher Name: Humana Press
Print ISBN: 978-1-58829-462-3
Online ISBN: 978-1-59259-995-0
eBook Packages: MedicineMedicine (R0)